Member Info for bignose58

Don't end up in a tree. I know they can be pretty powerful....lol

The.Italian.

Although you are now also involved with FUM, which I am sure you must have been watching, like me, for sometime, you didn't also happen to consider N4P?

I write this since N4P were also developing an ED product using a reformulation of Sildenafil (active ingredient of Viagra), although in Sept 2018 The Board identified that the risk reward profile to reformulate sildenafil to meet the required drug release profile was too great to continue and they since decided to close the generics division . They now seem to be spending their time and money developing Nuvec, a novel delivery system for vaccines which could be of use in collaborating with other companies developing C-19 vaccines ?

There certainly seems to be a lot of posts on the matter and the company has stated as such too. I see the share price is now heading North and could be a really good opportunity during the next few months if some of the other companies who mentioned C-19 are anything to go by (NCYT for example which has gone up 20 fold in a few weeks). NP4 still has a low market cap (6m) which is peanuts if compared.

I mention it here since it did have an ED product and the company is distantly linked to Dr Mike through, if I remember correctly, one of its employees who also worked at Pfizer. Interestingly Dr Mike did mention to me some years back that he felt the product reformulation wouldn't really be a show stopper since one could just take a Viagra tablet, crush it and rub it on the helmet to get the same effect...... :-)

Anyway, just a thought and maybe of some interest to you. It could also be of interest of a few others here too ?

The.Italian

Well that’s a turn up for the books. Lorne Abony stepping down as CEO and getting more involved in Yooma or is that just Yooya with a lisp, it’s till CBD related though. Obviously some jiggery pokery going on in Jim’s stable. He’s made a bolt for the door and I’m not referring to him becoming a blacksmith....lol

Speculatively, will RPG soon make an announcement about some CBD investment using money they don’t have and will it just be another DBC debacle ???

Will be an interesting next few days or maybe weeks or just nothing at all... :-)

Dougie,

No we wouldn't because, as I stated, this information has not been announced to the market.

Yes, yet another F&%k-up since they reduced the time period by 3 months when 6 months into the study, then by the end of the year, we are having to wait another 9 to twelve months which was not announced until March ..... It beggars belief. It's quite obvious this was known before the end of the year (you cannot tell me that they didn't know it would take longer until after 31st December). As such, an announcement should have been made long before, irrespective of it being a closed period.

Remember the study was announced to start in July/August 2018 which I had confirmed by JG at the time by email. We were then informed several weeks later it was delayed to start at the end of Dec2018/beginning of Jan 2019, no reasons given. Its Nothing more than pure incompetence and total contempt for shareholders. The CEO needs to go and his huge salary given to someone who is more competent like maybe a 6 year old.

It was the same with the HK/Macau debacle. shareholders were informed on a few occasions that the import license would take a year, which finally took two years and we are now heading towards 2 years post license award and still no launch......WTF.

They obviously are walking around with their heads stuck up their backsides....... And these are meant to be professional people !!!

Oh and I stay since I believe in the product, which I am sure will eventually get approval and sell, however. I am a lot less confident regarding the magnitude of US sales as I was given the disaster in the EU. Even with advertising, I am sure there will still be a modicum of stigma attached, which is not even discussed in the last presentation posted in March 2019 after the EU disastrous sales were known.

That said, I have no concerns about alternate products since there should be more than enough sufferers willing to try the different drugs. One only has to look at the ED market and the number of different marketed drugs available, including generics and most, if not all, companies are still making money.... ;-)

We will get there eventually.......... hopefully, as Keith states, we will all live to see it even with the C-19 floating about :-)

Bothwell

That's all well and good, so why do they persist in not informing the market of these facts instead of allowing the SP to disintegrate. This is the sort of information the investor community needs instead of just stating 6 years ago something to the effect that discussions are ongoing and they hope to sign agreements in the coming months. if they can make announcements about a possible TO of Yooya which came to absolutely nothing, they can surely inform the market on the US license agreement progress in more detail...no ? .

The USA license discussions have been ongoing long before the Chinese one which, as mentioned before, JG stated categorically face to face in June 2016 that China was not even a consideration due to the beauricratical red tape. Yet here we are with an agreement in place !!!

The pi's still here, and there are very few now, deserve much better. Some have been invested for more than 10 years and not just by buying shares on the open market, which does nothing with respect to supporting the company, but purchasing during the early placings (note how the pi's have had their balls removed with respect to subsequent placings since TO). The company namely JM and JG are sending a terrible signal regarding only allowing those with funny handshakes to partake or to fill their own pockets. It was during the early days when the company desperately needed funds when the pi's stepped in to help. Granted, monies were also sought from larger companies which have now been bought out, but remember its the hard earned private money out of Mr Joe averages pockets which means much more than the likes of companies who just use throw away money..... imho.. :-)

And just as a reminder the following is extracted from the PLE 11th March 2014 announcement regarding the unambiguous FDA approval process: "Negotiations are at a more advanced stage with a number of potential marketing partners
and the Company is hopeful that an announcement will be made in this regard over the coming
months". Granted that is also followed by a statement "Given the nature of licensing talks, it is not possible to
determine with accuracy the timing of completing such agreements". However, the fact that they mention "advanced" clearly indicate that signing an agreement could have been pretty close, yet, nothing and no reason given. This is surely unacceptable. If the license talks had broken down, which obviously they had. Investors had a right to know where the company stood or now stands.

Regarding the price point sensitivity they wrote about that with regard to the 6 dose cannister and then with the 12 dose cannister which now turns out to be more preferable with the 20 dose cannister. So why not start with the 20 dose cannister and change, if considered financially viable, later ?

No, I am sorry but the company has absolutely nothing but contempt for share holders who are now suffering with next to no news and a decimated share price.

Rant

That should have been....

https://www.numan.com/premature-ejaculation/delay-spray

And according to numan, 66% men in the UK suffer from ED and 40% from PE...... oh and they also make BBQ sauce.....LOL

After a closer look, it would seem they are producing the spray under their own label.
https://www.amazon.com/Promescent-Desensitizing-Clinically-Proven-Longer/dp/B07SQ48736

I went through the process, but didnee buy :-) and what do you know........
They are selling 3 types Priligy, delay wipes and of course a delay spray (Lidocaine 15%) otherwise known as Promescent, which can also be bought off Amazon in 2 sizes 0.07Fl Oz and 0.25 Fl Oz.
https://www.amazon.com/Promescent-Desensitizing-Clinically-Proven-Longer/dp/B07SQ48736

Its amazing how a 10k buy or sell (less than a 85 squid) can have a large impact on SP. Seems to me these 10k deals are being used to lower the price significantly and raise it significantly to meet deal requirements? I wouldn't be surprised if the brokers were not doing this themselves. It seems at the moment the range is between 0.07 and 0.08 with a wide spread.

But then what the F@#$ do I know....... ;-)

Yup, he certainly is.......

If we were to wait that long, Trump would still be president, but stuffed and remotely controlled by the Chinese. There would be more PE sufferers than population (according to RPG's internal modeling) and there would be a need of Fortacin for the sufferers on Mars.....LOL

On the 19th Feb 2018, the world population was 7,632,819,325, Today, 7th May 2020, the population is 7,782,736,950 = An increase of 149,917,625 (nearly 150 million). In just 808 days or 115 weeks....WTF !!!.

Assuming that the same numbers move up into the relevant age groups, that means, effectively, another 18.75million sufferers.........LOL

So, by the time we get US approval (say in another 2 years, going by current performance), there could be another 37,5million sufferers in the world and given that the US % in population is 4.25%, that equates to an additional 1.59 million sufferers in the good ol' USA.... ;-)

The.Italian. All we can do is email JM/JG and MW requesting they do these things, particularly since they are now false statement which the HKSX would not be happy about (I am sure they do not regulate as they should since there are far too many companies to follow up on - They probably relay on things like this being brought to their attention).

I am sure the only reason the gov website was updated yesterday is because I sent an email the evening before stating that it was a website requirement. Although I did request, not too kindly, for detailed info on the so called "concrete" works as well as pointing out that it doesn't now take seven years to complete a phase II trial after announcing they had an unambiguous agreement with the FDA in March 2014, he is far too arrogant to reply.

We are effectively paying his salary, so he should be subjected to correspondence pointing out the companies/his failing. No point in getting all angry about it if we are not prepared to say anything. It may go unanswered, but I am sure once pointed out, he would not be willing to expose himself to the scrutiny of the HKSX as there will be no excuses, particularly since he is meant to be a lawyer and should know better. n'est'pa ?

It certainly makes no sense. First, the commencement date was delayed by 6 months (remember that one? July 2019 changed to Dec 2019) then, after only 6 months into the study, they knock 20% off the expected date Only to now go and extend it by 100%. This surely indicates there has been a major **** up somewhere along the line, which I guess should have been expected given the past bad performance on unmet dates. IMHO...of course.....lol

Finally updated today.... https://clinicaltrials.gov/ct2/show/NCT03578783

Only exactly one year on from a date which had been back dated from an original March 2020. Well I'll give them this. They are consistent in not getting any predicted dates correct....ever.......

She might be called stella mushroom though........lol

stella fung................

Look back through your own posts, you will find Stella fungus email address. Also, the date of when the posts were made. Easy enough.

Hi The.Italian. Yup off a cliff. Today was just a below 10k block, hence the Low price. Fortunately, this time, it didnt impact the sp. I’m sure the only significance is that holders have lost any appetite to trade at the current level... ;-)

Notice of AGM 17th June.

One point is to reelect JM and David Comba as directors.......Biographical details of the retiring Directors are set out in the shareholders’ circular dated 29 April 2020 .....whose retiring.....I hear an applause coming on........LOL

Mr Mellon receives an annual fee of US$25,000 and an annual advisory fee of US$157,500....= 182,500USD (take note JG since that's more than you are worth).

Mr Comba receives an annual director’s fee of US$40,000 (take note JG since that is twice what you are worth).

:-)